BRIEF-Horizon discovery and Astrazeneca sign oncology research and license agreement

Tue Jan 7, 2014 4:02am EST

Jan 7 (Reuters) - Horizon Discovery: * Horizon discovery and Astrazeneca have entered into a research, collaboration and license agreement * Agreement to explore a range of oncology-relevant genotypes * Will receive an undisclosed upfront payment * Eligible for subsequent payments of up to $88 mln in milestones if compounds are developed by Astrazeneca * Source text for Eikon: * For more news, please click here

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.